These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33837406)

  • 21. daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Rose WE; Leonard SN; Sakoulas G; Kaatz GW; Zervos MJ; Sheth A; Carpenter CF; Rybak MJ
    Antimicrob Agents Chemother; 2008 Mar; 52(3):831-6. PubMed ID: 17999971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
    LaPlante KL; Woodmansee S
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3880-6. PubMed ID: 19564363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.
    Miró JM; Entenza JM; Del Río A; Velasco M; Castañeda X; Garcia de la Mària C; Giddey M; Armero Y; Pericàs JM; Cervera C; Mestres CA; Almela M; Falces C; Marco F; Moreillon P; Moreno A;
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4511-5. PubMed ID: 22644033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
    Rehm SJ; Boucher H; Levine D; Campion M; Eisenstein BI; Vigliani GA; Corey GR; Abrutyn E
    J Antimicrob Chemother; 2008 Dec; 62(6):1413-21. PubMed ID: 18782781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.
    de Górgolas M; Avilés P; Verdejo C; Fernández Guerrero ML
    Antimicrob Agents Chemother; 1995 Apr; 39(4):953-7. PubMed ID: 7786002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
    Kaatz GW; Seo SM; Reddy VN; Bailey EM; Rybak MJ
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
    Duss FR; Garcia de la Mària C; Croxatto A; Giulieri S; Lamoth F; Manuel O; Miró JM
    J Antimicrob Chemother; 2019 Sep; 74(9):2626-2630. PubMed ID: 31298264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
    Brinch KS; Tulkens PM; Van Bambeke F; Frimodt-Møller N; Høiby N; Kristensen HH
    J Antimicrob Chemother; 2010 Aug; 65(8):1720-4. PubMed ID: 20534628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Leonard SN; Rybak MJ
    J Antimicrob Chemother; 2009 Jan; 63(1):155-60. PubMed ID: 18984644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
    Tattevin P; Basuino L; Bauer D; Diep BA; Chambers HF
    Antimicrob Agents Chemother; 2010 Feb; 54(2):610-3. PubMed ID: 19917746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effectiveness of various antibiotics in the treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis.
    Apellaniz G; Valdés M; Perez R; Martin F; Soria F; Garcia A; Gòmez J; Vicente T
    J Chemother; 1991 Apr; 3(2):91-7. PubMed ID: 1875239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Jacqueline C; Amador G; Batard E; Le Mabecque V; Miègeville AF; Biek D; Caillon J; Potel G
    J Antimicrob Chemother; 2011 Apr; 66(4):863-6. PubMed ID: 21393213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of daptomycin-, vancomycin-, and teicoplanin-loaded polymethylmethacrylate against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate strains of Staphylococcus aureus.
    Chang Y; Chen WC; Hsieh PH; Chen DW; Lee MS; Shih HN; Ueng SW
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5480-4. PubMed ID: 21930872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection.
    Meije Y; Almirante B; Del Pozo JL; Martín MT; Fernández-Hidalgo N; Shan A; Basas J; Pahissa A; Gavaldà J
    J Infect; 2014 Jun; 68(6):548-52. PubMed ID: 24412247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.
    Garrigós C; Murillo O; Lora-Tamayo J; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3806-11. PubMed ID: 22585211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
    Steed ME; Werth BJ; Ireland CE; Rybak MJ
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5709-14. PubMed ID: 22908167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE).
    Cunha BA; Pherez FM
    Eur J Clin Microbiol Infect Dis; 2009 Jul; 28(7):831-3. PubMed ID: 19184141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of telavancin activity versus daptomycin and vancomycin against daptomycin-nonsusceptible Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Steed ME; Vidaillac C; Rybak MJ
    Antimicrob Agents Chemother; 2012 Feb; 56(2):955-9. PubMed ID: 22123693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
    Lemaire S; Olivier A; Van Bambeke F; Tulkens PM; Appelbaum PC; Glupczynski Y
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2797-805. PubMed ID: 18519727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.